FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$56.20 B | $58.05 B | $54.32 B | $56.33 B | $61.16 B | $62.82 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$17.45 B | $17.41 B | $20.42 B | $16.90 B | $9.97 B | $16.67 B |
Gross Profit Revenue minus cost of revenue. |
|
$38.75 B | $40.64 B | $33.90 B | $39.43 B | $51.20 B | $46.15 B |
|
Operating Expense
Costs to run business. 
|
|
$20.83 B | $22.52 B | $21.15 B | $30.29 B | $29.98 B | $28.81 B |
Operating Income Profit from operations. |
|
$17.92 B | $18.12 B | $12.76 B | $9.14 B | $21.21 B | $17.34 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$2.38 B | -$2.04 B | -$1.68 B | -$2.16 B | -$2.63 B | -$2.65 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$2.51 B | $2.41 B | $4.28 B | $2.61 B | $11.99 B | $5.48 B |
Total Other Income (Net) Net non-operating items. |
|
-$4.94 B | -$4.64 B | -$6.51 B | -$5.42 B | -$14.62 B | -$11.37 B |
Income Before Tax Profit before taxes. |
|
$12.99 B | $13.48 B | $6.25 B | $3.72 B | $6.60 B | $5.98 B |
Income Tax Expense Taxes on income. |
|
$1.44 B | $1.63 B | $1.38 B | -$570.00 M | $2.36 B | $2.33 B |
|
Net Income
Final profit.
|
|
$11.54 B | $11.84 B | $4.86 B | $4.28 B | $4.23 B | $3.64 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$6.48 | $6.65 | $2.73 | $2.40 | $2.38 | $2.04 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$6.45 | $6.63 | $2.72 | $2.39 | $2.36 | $2.04 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
1.77 B | 1.77 B | 1.77 B | 1.77 B | 1.79 B | 1.77 B |
Diluted Average Shares Outst. Shares including dilution. |
|
1.78 B | 1.78 B | 1.77 B | 1.77 B | 1.79 B | 1.77 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$15.41 B | $15.71 B | $8.47 B | $6.52 B | $9.22 B | $11.86 B |
EBITDA Earnings before interest, tax, D&A. |
|
$23.93 B | $24.17 B | $17.17 B | $14.91 B | $28.29 B | $17.96 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$8.52 B | $8.47 B | $8.70 B | $8.39 B | $19.07 B | $6.10 B |
| Company Report |
FY 2025
AbbVie's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
AbbVie's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
AbbVie's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
AbbVie's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
